A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1992
11/19/1992	EP0249620B1 Process for the preparation of quinoline carboxylic acids
11/18/1992	CN1066292A Compounds, named "leustroducsins", their preparation and their therapeutic uses
11/18/1992	CN1066270A Pharmaceutical compounds
11/18/1992	CN1066192A Pulmonary administration of granulocyte colony stimulating factor
11/18/1992	CN1066186A Pharmaceutical formulation containing dirithromycin
11/18/1992	CN1066170A Glycine anhydride dimethylol as biocide and preservative
11/18/1992	CA2068817A1 Vaccines and methods for their production
11/17/1992	US5164507 Fungicide
11/17/1992	US5164414 Antitumor
11/17/1992	US5164375 Antifungal agent
11/17/1992	CA2068853A1 Substituted carboxy amino azetidinyl pyridone derivatives; process for preparing the same and their use as drugs
11/17/1992	CA1310445C Derivatives of aminopimelic acid, process for their preparation and their application as medecines
11/17/1992	CA1310443C Glutamic acid derivatives, their salts, process of preparation, applications as medications, and compositions containing them
11/14/1992	CA2068561A1 O-aryl, o-alkyl, o-alkenyl and o-alkynylmacrolides having immunosuppressive activity
11/12/1992	WO1992019750A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor
11/12/1992	WO1992019748A1 Herpesvirus particles and vaccine
11/12/1992	WO1992019743A2 Hcv genomic sequences for diagnostics and therapeutics
11/12/1992	WO1992019742A1 NOVEL HYBRID, SOLUBLE AND UNCLEAVED gp160 VARIANT
11/12/1992	WO1992019741A1 Hbv virus surface proteins with reduced host carbohydrate
11/12/1992	WO1992019740A1 Multiple hepatitis b virus surface proteins which form particles
11/12/1992	WO1992019646A1 Analog of endothelial leukocyte adhesion molecule (elam)
11/12/1992	WO1992019607A1 Dibenzothiazepinthione as antiviral agents
11/12/1992	WO1992019277A1 Antiviral dibenzothiazepinone derivatives
11/12/1992	WO1992019268A1 New hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines
11/12/1992	WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes
11/12/1992	WO1992019212A2 Glycine anhydride dimethylol as a biocide and preservative
11/12/1992	DE4212132A1 Propolisbestandteile enthaltendes feststoffprodukt, seine herstellung und verwendung Propolis-containing solid product, its production and use
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes
11/11/1992	WO1992020851A1 Sewing machine needle and method of manufacturing same
11/11/1992	WO1992020697A1 3'-end blocked oligonucleotides
11/11/1992	WO1992020358A1 Novel biologically active peptide compositions and uses therefor
11/11/1992	WO1992000749A1 Anti-herpes virus and cytomegalovirus oligomers
11/11/1992	EP0512902A1 Dialkyleneperidino compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them
11/11/1992	EP0512824A1 Anti-bacterial compound
11/11/1992	EP0512754A1 Reduction products of rapamycin as immunosuppressants antiinflammatory or antifungal agents
11/11/1992	EP0512522A1 Novel antibiotic compounds and their production
11/11/1992	EP0512349A1 Benzothiophene-2-carboxamide-S,S-dioxides
11/11/1992	EP0512343A2 Amino acid derivatives and their use as anti-viral agents
11/11/1992	EP0512260A2 Stable pura vectors and uses thereof
11/11/1992	EP0512023A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
11/11/1992	EP0409862B1 Topical preparations
11/11/1992	EP0305470B1 Antiinfective compounds and method of use
11/11/1992	CN1065997A 疫苗 Vaccine
11/11/1992	CA2102804A1 3'-end blocked oligonucleotides
11/11/1992	CA2086111A1 Biologically active peptide compositions and uses therefor
11/10/1992	US5162569 Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives
11/10/1992	US5162538 Antiviral new peptides
11/10/1992	US5162523 Cephalosporin antibacterial compounds
11/10/1992	US5162512 Treatment of cellular disorders
11/10/1992	US5162368 Butalactin and its use as pharmaceutical
11/10/1992	US5162356 Azole mycocide and method of treating mycosis
11/10/1992	US5162348 Treatment of cystic fibrosis
11/10/1992	US5162330 Dynemicin c antibiotic, its triacetyl derivative and pharmaceutical composition containing same
11/10/1992	US5162309 Mono (2-ammonium-2-hydroxymethyl-1,3-propanediol)(2r,cis)-1,2-ep-oxipropyl-phosphonate with improved characteristics of stability and processing
11/10/1992	US5162112 Influenza vaccine
11/10/1992	US5162111 Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor
11/09/1992	WO1992019267A1 Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them
11/04/1992	WO1992019752A1 Rna delivery vector
11/04/1992	WO1992019247A1 Erythromycin derivatives
11/04/1992	WO1992019232A1 Partial liquid breathing of fluorocarbons
11/04/1992	EP0511866A2 Process for the crystallization of cyclic lipopeptides
11/04/1992	EP0511855A1 HBsAg escape mutant vaccine
11/04/1992	EP0511854A1 Multiple hepatitis B virus surface proteins which form particles
11/04/1992	EP0511800A1 Pharmaceutical formulation containing dirithromycin
11/04/1992	EP0511799A1 Pharmaceutical compounds
11/04/1992	EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
11/04/1992	EP0511285A1 Vector with multiple target response elements affecting gene expression
11/04/1992	EP0498843A4 Oligonucleotide analogs with novel linkages
11/04/1992	EP0437554B1 Pharmaceutical composition and method of inhibiting virus
11/04/1992	EP0317568B1 Use of granulocyte macrophage colony stimulating factor to prepare a medicament for treating bacterial infections
11/04/1992	CN1065867A Peptides and mixtures thereof for detecting antibodies to hepatitis c virus
11/04/1992	CA2107793A1 Erythromycin derivatives
11/04/1992	CA2086510A1 Rna delivry vector
11/04/1992	CA2067834A1 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
11/03/1992	WO1992019594A1 Pyrrolidinones
11/03/1992	WO1992019265A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	WO1992019246A1 Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection
11/03/1992	US5160737 Acrylic copolymer; sustained release; dentistry, dermatology
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	CA2102120A1 Use of a 1,3-oxathlolan derivative for the treatment of hepatitis b infection
11/03/1992	CA2102106A1 Pyrrolidinones
11/03/1992	CA2102105A1 Recombinant dna-derived cholera toxin subunit analogs
11/03/1992	CA2067598A1 Recombinant adn molecules coding for a receptor chain for the t-cell antigen, preparation process, antibody and drugs containing them
11/02/1992	WO1992019725A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them
11/02/1992	CA2109418A1 Glycine anhydride dimethylol as a biocide and preservative
11/02/1992	CA2085597A1 Human rotavirus hcr3, reassortants thereof and vaccine compositions containing them
11/02/1992	CA2067294A1 Process for crystalline cyclic lipopeptides
10/1992
10/30/1992	CA2067590A1 Multiple hepatitis b virus surface proteins which form particles
10/30/1992	CA2067290A1 Hepatitis b virus surface proteins with reduced host carbohydrate content
10/30/1992	CA2067003A1 Hbsag escape mutant vaccine
10/29/1992	WO1992018624A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor
10/29/1992	WO1992018508A1 New cephem compounds
10/29/1992	WO1992018497A1 Novel difluorinated quinolones, their preparation method and pharmaceutical compositions containing same
10/29/1992	WO1992018496A1 New thalidomide derivatives, method of manufacture and use thereof in medicaments
10/29/1992	WO1992018490A1 Novel dna gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
10/29/1992	WO1992018486A1 Improved process for the preparation of [1s-(1r, 2s, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n-[(1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
10/29/1992	WO1992018485A1 Anti-cancer coumpounds
10/29/1992	WO1992018158A1 Method and composition for the treatment of herpes related disorders
10/29/1992	WO1992018140A1 Activity-dependent neurotrophic factor

1 ... 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 ... 1798